• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA 34a和Let-7a在人类乳腺癌中的表达与凋亡相关基因的表达有关。

Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.

作者信息

Mansoori Behzad, Mohammadi Ali, Shirjang Solmaz, Baghbani Elham, Baradaran Behzad

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran E-mail :

出版信息

Asian Pac J Cancer Prev. 2016;17(4):1887-90. doi: 10.7314/apjcp.2016.17.4.1887.

DOI:10.7314/apjcp.2016.17.4.1887
PMID:27221871
Abstract

Breast cancer is the most common cause of cancer-related death among women in the whole world. MiR- 34a and let-7a are well known tumor suppressors that participate in the regulation of apoptosis, invasion and other cellular functions. In this study, expression of miR-34a, let-7a and apoptosis pathway genes such as Bcl-2, Caspase-3 and P53 were evaluated using quantitative real-time PCR in 45 paired samples of normal margin and tumor tissue collected from breast cancer patient at advanced stage (3-4). MiR-34a, let-7a, caspase-3 and P53 expression are reduced and Bcl-2 expression is increased within tumoral tissues in comparison with normal margin tissues. P53 expression directly or indirectly was correlated with miR-34a, let-7a, Bcl-2 and caspase-3 expression. In This study we found that MiR-34a and let-7a expression are reduced in the tumoral tissues. Down- regulation of these two molecules correlated with expression of genes associated with apoptosis. These results suggest that due to the correlation of miR-34a and let-7a with apoptotic and anti-apoptotic pathways these molecules could participate as regulators in advanced clinical stages of breast cancer and should be considered as markers for diagnosis, prognostic assessment and targeted therapy.

摘要

乳腺癌是全球女性癌症相关死亡的最常见原因。MiR-34a和let-7a是众所周知的肿瘤抑制因子,参与细胞凋亡、侵袭及其他细胞功能的调节。在本研究中,采用定量实时PCR对45对取自晚期(3 - 4期)乳腺癌患者的正常边缘组织和肿瘤组织样本进行检测,评估MiR-34a、let-7a及凋亡通路相关基因如Bcl-2、Caspase-3和P53的表达。与正常边缘组织相比,肿瘤组织中MiR-34a、let-7a、Caspase-3和P53的表达降低,而Bcl-2的表达增加。P53的表达与MiR-34a、let-7a、Bcl-2和Caspase-3的表达直接或间接相关。在本研究中我们发现,肿瘤组织中MiR-34a和let-7a的表达降低。这两种分子的下调与凋亡相关基因的表达有关。这些结果表明,由于MiR-34a和let-7a与凋亡和抗凋亡通路相关,这些分子可能在晚期乳腺癌临床阶段作为调节因子发挥作用,应被视为诊断、预后评估和靶向治疗的标志物。

相似文献

1
Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.微小RNA 34a和Let-7a在人类乳腺癌中的表达与凋亡相关基因的表达有关。
Asian Pac J Cancer Prev. 2016;17(4):1887-90. doi: 10.7314/apjcp.2016.17.4.1887.
2
Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.肿瘤抑制性微小RNA-34a通过靶向致癌蛋白TPD52抑制乳腺癌细胞的迁移和侵袭。
Tumour Biol. 2016 Jun;37(6):7481-91. doi: 10.1007/s13277-015-4623-4. Epub 2015 Dec 17.
3
MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer.miR-34a 的表达降低了转移的风险,并与预测乳腺癌临床结局的表达模式相关。
PLoS One. 2011;6(11):e26122. doi: 10.1371/journal.pone.0026122. Epub 2011 Nov 10.
4
Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.紫杉醇治疗下,let-7a和miR-205肿瘤抑制性微小RNA在不同亚型乳腺癌中的差异表达变化
Adv Clin Exp Med. 2018 Jul;27(7):941-945. doi: 10.17219/acem/70745.
5
Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.评估 miRNA-9 和 miRNA-34a 作为伊朗女性乳腺癌诊断的潜在生物标志物。
Gene. 2019 Mar 1;687:272-279. doi: 10.1016/j.gene.2018.11.036. Epub 2018 Nov 20.
6
[Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].受let-7/miR-98家族调控的骨膜蛋白介导结肠癌的凋亡和上皮-间质转化
Zhonghua Zhong Liu Za Zhi. 2019 Aug 23;41(8):573-579. doi: 10.3760/cma.j.issn.0253-3766.2019.08.004.
7
MicroRNA profile in site-specific head and neck squamous cell cancer.特定部位头颈部鳞状细胞癌中的微小RNA谱
Anticancer Res. 2015 Apr;35(4):2455-63.
8
Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.let-7a-5p的下调可预测结直肠癌的淋巴结转移和预后:对化疗的意义。
Surg Oncol. 2016 Dec;25(4):429-434. doi: 10.1016/j.suronc.2016.05.016. Epub 2016 May 27.
9
Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer.肿瘤抑制因子miR-195和let-7a的表达作为浸润性乳腺癌的潜在生物标志物。
Clinics (Sao Paulo). 2018 Jul 10;73:e184. doi: 10.6061/clinics/2018/e184.
10
Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.胃动蛋白1通过下调RhoA表达抑制胃癌细胞的迁移和侵袭。
Gastric Cancer. 2017 Mar;20(2):274-285. doi: 10.1007/s10120-016-0617-1. Epub 2016 Jun 1.

引用本文的文献

1
Unveiling the intricacies: small interfering RNA targeting Snail-1 unravels dynamics in endometrial carcinoma cell behavior.揭示复杂性:靶向Snail-1的小干扰RNA揭示子宫内膜癌细胞行为的动态变化。
Front Oncol. 2025 Jun 12;15:1567493. doi: 10.3389/fonc.2025.1567493. eCollection 2025.
2
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.通过抑制 ABCC1 基因,恢复 microRNA-34a 可克服人乳腺癌细胞系中的获得性耐药和疾病进展。
Breast Cancer Res Treat. 2024 Feb;204(1):133-149. doi: 10.1007/s10549-023-07170-0. Epub 2023 Dec 7.
3
MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and Study.
miR-146a恢复可抑制三阴性乳腺癌细胞迁移:一项生物信息学及研究
Adv Pharm Bull. 2022 Aug;12(4):842-849. doi: 10.34172/apb.2022.083. Epub 2021 Oct 6.
4
Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.循环 microRNAs 从分子机制到临床生物标志物:以透明细胞肾细胞癌为例。
Genes (Basel). 2021 Jul 28;12(8):1154. doi: 10.3390/genes12081154.
5
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.miR-34a 和 miR-200c 对乳腺癌细胞和患者预后有累加的肿瘤抑制作用。
Genes (Basel). 2021 Feb 12;12(2):267. doi: 10.3390/genes12020267.
6
Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-β1 axis.白细胞介素-18 通过 miR-574-3p/TGF-β1 轴促进结直肠癌中自然杀伤细胞的抗肿瘤能力。
Bioengineered. 2021 Dec;12(1):763-778. doi: 10.1080/21655979.2021.1880717.
7
Restoring of miR-193a-5p Sensitizes Breast Cancer Cells to Paclitaxel through P53 Pathway.miR-193a-5p的恢复通过P53途径使乳腺癌细胞对紫杉醇敏感。
Adv Pharm Bull. 2020 Sep;10(4):595-601. doi: 10.34172/apb.2020.071. Epub 2020 Aug 9.
8
Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.唾液 microRNA miR-let-7a-5p 和 miR-3928 可用作头颈部鳞状细胞癌的潜在诊断生物标志物。
PLoS One. 2020 Mar 24;15(3):e0221779. doi: 10.1371/journal.pone.0221779. eCollection 2020.
9
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?循环非编码 RNA 标志物在三阴性乳腺癌新辅助化疗中的潜力?
Int J Oncol. 2020 Jan;56(1):47-68. doi: 10.3892/ijo.2019.4920. Epub 2019 Nov 25.
10
Genetic and molecular biology of breast cancer among Iranian patients.伊朗患者乳腺癌的遗传和分子生物学。
J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2.